Dr. Kristen L. Russomanno, MD

Dr. Russomanno practices at MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health.

Dr. Russomanno's NPI, 1184156762, was assigned on April 1, 2017. Dr. Russomanno graduated from University of Connecticut School of Medicine in 2017. Dr. Russomanno holds District of Columbia license MD210002405.

Dr. Russomanno's primary practice is MedStar Washington Hospital Center, at 110 Irving Street NW, Washington, DC 20010 in The District County. The practice phone is (202) 877-7000.

Dr. Russomanno's primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Russomanno to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Russomanno practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Russomanno's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Russomanno is licensed in District of Columbia.

CMS data shows 1,192 Medicare services from Dr. Russomanno across 11 procedure codes in 2024, for 292 Medicare patients. Medicare paid $58,882 for them. Every service was in an office.

CMS counts 292 Medicare patients who saw Dr. Russomanno in 2024. The largest group is 65 to 74, with 164 patients. 67% of them have high cholesterol, and 66% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Russomanno's median patient age at 45, with 62% women.

In 2024, Dr. Russomanno wrote 804 Medicare Part D claims for 224 patients. 86% of them were for generic drugs. CMS names the drug for 697 of them, across 20 drugs with 11 or more claims each, at $181,011 in total drug cost. In 2023, CMS named 319 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Russomanno for performance year 2024, reported as part of a group. Dr. Russomanno accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Russomanno as offering telehealth. CMS counts 344 procedures of removal of skin lesions by Dr. Russomanno, more than 83% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Russomanno, published from 2020 to 2023. 2021 was the busiest year, with 4. The most frequent topics are Skin Neoplasms. Dr. Russomanno has published most often in Pediatr Dermatol. Dr. Russomanno's most frequent co-authors are Michael Andrew Cardis, MD, Min Deng, MD and Alison Hill, MD.

CMS Open Payments shows 5 general payments to Dr. Russomanno from 4 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Galderma Laboratories, L.P. paid the most, $84.

Dr. Russomanno graduated from University of Connecticut School of Medicine in 2017.